ArticlePhotoacoustics2026
Real-time deep learning-based vascular recognition in clinical breast photoacoustic imaging.
Article in Photoacoustics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Breast imaging is a primary application of photoacoustic computed tomography. However, in current clinical environments, existing technologies cannot perform real-time vascular recognition during the scanning process. We propose a deep learning-based vascular recognition method. A physics-informed simulation workflow was constructed to train the network, alleviating the challenge of scarce high-quality clinical data. By optimizing the proposed HAR-UNet (Hybrid Attention Residual U-Net), an end-to-end processing speed of 18.08 fps was achieved. This high-frame-rate output enables real-time clinical vascular recognition. Furthermore, the clinical translational potential of this method was evaluated on an in vivo cohort of breast cancer patients. The proposed framework enables synchronous clinical vascular scanning and recognition. Quantitative analysis performed on 23 valid cases effectively assessed tumor angiogenesis biomarkers, differentiating tumors from normal tissues with a
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.